Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa Lheriteau

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Blood Reviews|June 8, 2015
Haemophilia gene therapy: Progress and challengesElsa Lheriteau, Andrew M Davidoff, Amit C Nathwani
Frontiers in Immunology|March 6, 2023
LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantationJuliette Rousse, Pierre-Joseph Royer, Gwénaëlle Evanno, et al.
Frontiers in Immunology|December 6, 2021
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes VariantsBernard Vanhove, Stéphane Marot, Ray T So, et al.
Frontiers in Immunology|May 15, 2023
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variantsBernard Vanhove, Stéphane Marot, Ray T So, et al.
Plos One|June 10, 2016
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea PigsOlivier Reynard, Frédéric Jacquot, Gwénaëlle Evanno, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2Bernard Vanhove, Odile Duvaux, Juliette Rousse, et al.
European Journal of Immunology|February 12, 2021
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2Bernard Vanhove, Odile Duvaux, Juliette Rousse, et al.
The New England Journal of Medicine|November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia BAmit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Blood Reviews|June 8, 2015
Haemophilia gene therapy: Progress and challengesElsa Lheriteau, Andrew M Davidoff, Amit C Nathwani
Frontiers in Immunology|March 6, 2023
LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantationJuliette Rousse, Pierre-Joseph Royer, Gwénaëlle Evanno, et al.
Frontiers in Immunology|December 6, 2021
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes VariantsBernard Vanhove, Stéphane Marot, Ray T So, et al.
Frontiers in Immunology|May 15, 2023
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variantsBernard Vanhove, Stéphane Marot, Ray T So, et al.
Plos One|June 10, 2016
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea PigsOlivier Reynard, Frédéric Jacquot, Gwénaëlle Evanno, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2Bernard Vanhove, Odile Duvaux, Juliette Rousse, et al.
European Journal of Immunology|February 12, 2021
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2Bernard Vanhove, Odile Duvaux, Juliette Rousse, et al.
The New England Journal of Medicine|November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia BAmit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
Pageof 1